Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7531982rdf:typepubmed:Citationlld:pubmed
pubmed-article:7531982lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C0038585lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C0243046lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C0073994lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C1262479lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7531982lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7531982pubmed:issue2lld:pubmed
pubmed-article:7531982pubmed:dateCreated1995-3-22lld:pubmed
pubmed-article:7531982pubmed:abstractTextWe have examined the effects of salmon calcitonin (SCT), injected into the cerebral ventricle (i.c.v.), on the tail-biting and scratching behavior induced by the intrathecal injection of different types of nociceptive agents, i.e., substance P, N-methyl-D-aspartate (NMDA), kainate (KA), and quisqualate (Quis). Tail-biting and scratching behavior induced by the 4 substances was significantly inhibited by SCT (i.c.v.) in the same manner: the dose-response curves were U-shaped, and the most effective dose was 0.1 IU/mouse in all cases. SCT did not, however, completely inhibit tail-biting and scratching behavior. At its most effective dose, the percent inhibition of substance P-, NMDA-, KA- and Quis-induced behavior were 77.9%, 40.2%, 49.4%, and 52.9%, respectively. These results suggest that SCT has the inhibitory effects of substance P- and glutamate receptor agonists-induced nociceptive response in vivo.lld:pubmed
pubmed-article:7531982pubmed:languageenglld:pubmed
pubmed-article:7531982pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:citationSubsetIMlld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7531982pubmed:statusMEDLINElld:pubmed
pubmed-article:7531982pubmed:issn0300-9564lld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:FukuiSSlld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:YamadaKKlld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:MaedaYYlld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:HasegawaTTlld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:NabeshimaTTlld:pubmed
pubmed-article:7531982pubmed:authorpubmed-author:LuN MNMlld:pubmed
pubmed-article:7531982pubmed:issnTypePrintlld:pubmed
pubmed-article:7531982pubmed:volume96lld:pubmed
pubmed-article:7531982pubmed:ownerNLMlld:pubmed
pubmed-article:7531982pubmed:authorsCompleteYlld:pubmed
pubmed-article:7531982pubmed:pagination125-33lld:pubmed
pubmed-article:7531982pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:meshHeadingpubmed-meshheading:7531982-...lld:pubmed
pubmed-article:7531982pubmed:year1994lld:pubmed
pubmed-article:7531982pubmed:articleTitleInhibitory effects of salmon calcitonin on the tail-biting and scratching behavior induced by substance P and three excitatory amino acids.lld:pubmed
pubmed-article:7531982pubmed:affiliationDepartment of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University School of Medicine, Japan.lld:pubmed
pubmed-article:7531982pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7531982pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed